We are live on ! Find out more
IC

Inscription Capital Portfolio holdings

AUM $951M
1-Year Est. Return 23.82%
This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+23.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$928M
AUM Growth
+$234M
Cap. Flow
+$183M
Cap. Flow %
19.72%
Top 10 Hldgs %
29.75%
Holding
668
New
189
Increased
333
Reduced
84
Closed
30

Top Buys

Rank Stock Value
1
PULS icon
PGIM Ultra Short Bond ETF
PULS
+$18.1M
2
AAPL icon
Apple
AAPL
+$2.73M
3
NVDA icon
NVIDIA
NVDA
+$2.55M
4
MSFT icon
Microsoft
MSFT
+$2.47M
5
CVX icon
Chevron
CVX
+$2.06M

Sector Composition

Rank Sector Weight
1 Technology 18.25%
2 Consumer Discretionary 8.36%
3 Financials 7.03%
4 Industrials 6.61%
5 Consumer Staples 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
401
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$413K 0.04%
2,966
-457
-13% -$61.8K
CMCSA icon
402
Comcast
CMCSA
$90B
$412K 0.04%
13,105
+1,551
+13% +$52K
NEM icon
403
Newmont
NEM
$119B
$411K 0.04%
4,877
+522
+12% +$36.4K
TOST icon
404
Toast
TOST
$19.9B
$410K 0.04%
11,236
+2,832
+34% +$123K
WAB icon
405
Wabtec
WAB
$49.3B
$406K 0.04%
2,024
+41
+2% +$8.09K
TRV icon
406
Travelers Companies
TRV
$80.2B
$403K 0.04%
1,443
+13
+0.9% +$3.48K
EXC icon
407
Exelon
EXC
$47B
$401K 0.04%
+8,920
New +$392K
CLS icon
408
Celestica
CLS
$36.5B
$401K 0.04%
1,629
-917
-36% -$185K
WST icon
409
West Pharmaceutical
WST
$24.9B
$398K 0.04%
+1,519
New +$369K
VIVK
410
Vivakor
VIVK
$923K
$397K 0.04%
236
IONQ icon
411
IonQ
IONQ
$16.6B
$397K 0.04%
6,455
+160
+3% +$7.52K
BMY icon
412
Bristol-Myers Squibb
BMY
$132B
$393K 0.04%
8,722
+1,576
+22% +$73.6K
MSA icon
413
Mine Safety
MSA
$7.49B
$390K 0.04%
2,268
-1,315
-37% -$227K
BIO icon
414
Bio-Rad Laboratories Class A
BIO
$9.42B
$389K 0.04%
+1,388
New +$378K
AXP icon
415
American Express
AXP
$230B
$387K 0.04%
1,166
+51
+5% +$16.2K
W icon
416
Wayfair
W
$14.6B
$386K 0.04%
+4,322
New +$317K
VICI icon
417
VICI Properties
VICI
$29.4B
$385K 0.04%
11,816
+2,515
+27% +$82.9K
AHR icon
418
American Healthcare REIT
AHR
$10.9B
$385K 0.04%
9,159
-822
-8% -$33K
AZTA icon
419
Azenta
AZTA
$1.48B
$385K 0.04%
13,389
-579
-4% -$17.9K
MANH icon
420
Manhattan Associates
MANH
$11.4B
$384K 0.04%
1,871
-348
-16% -$73.6K
AIG icon
421
American International
AIG
$41.3B
$383K 0.04%
+4,872
New +$389K
COF icon
422
Capital One
COF
$134B
$380K 0.04%
1,788
+186
+12% +$40.7K
OMC icon
423
Omnicom Group
OMC
$23.4B
$378K 0.04%
4,640
+191
+4% +$14.4K
CTRA
424
DELISTED
Coterra Energy
CTRA
$376K 0.04%
15,917
-1,008
-6% -$24.3K
XLY icon
425
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$375K 0.04%
3,130
+156
+5% +$17.9K

Similar funds

Inscription Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Inscription Capital held 668 positions worth $928M, up 34% from $694M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Inscription Capital deployed $183M of net new capital in Q3 2025, opening 189 new positions and adding to 333 existing holdings. Its largest new stake was PGIM Ultra Short Bond ETF: 363,451 shares worth $18.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $4.09M trimmed.

  • Inscription Capital's largest Q3 2025 buy was PGIM Ultra Short Bond ETF: 363,451 shares worth $18.1M.
  • Inscription Capital added most to Apple in Q3 2025, an estimated $2.73M increase.
  • Inscription Capital's biggest Q3 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $4.09M.
  • Inscription Capital fully exited Hess in Q3 2025, selling an estimated $1.3M.
  • Inscription Capital's ten largest holdings make up 30% of its $928M portfolio in Q3 2025.
  • Inscription Capital opened 189 new positions and closed 30 in Q3 2025.
  • Inscription Capital's portfolio value rose 34% quarter-over-quarter to $928M.

Based on Inscription Capital's 13F filing for Q3 2025, filed 29 Oct 2025.